Bodo J - Search Results

1

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Hu Y, Liu H, Fang C, Li C, Xhyliu F, Dysert H, Bodo J, Habermehl G, Russell BE, Li W, Chappell M, Jiang X, Ondrejka SL, Hsi ED, Maciejewski JP, Yi Q, Anderson KC, Munshi NC, Ao G, Valent JN, Lin J, Zhao J. Hu Y, et al. Among authors: bodo j. Cancer Res. 2020 May 15;80(10):2031-2044. doi: 10.1158/0008-5472.CAN-19-1077. Epub 2020 Mar 19. Cancer Res. 2020. PMID: 32193289 Free PMC article.

2

Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.

Zuluaga Toro T, Hsieh FH, Bodo J, Dong HY, Hsi ED. Zuluaga Toro T, et al. Among authors: bodo j. Br J Haematol. 2007 Oct;139(1):31-40. doi: 10.1111/j.1365-2141.2007.06708.x. Epub 2007 Jul 27. Br J Haematol. 2007. PMID: 17662084 Free article.

3

Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.

Bodo J, Durkin L, Hsi ED. Bodo J, et al. J Histochem Cytochem. 2009 Jul;57(7):701-8. doi: 10.1369/jhc.2009.953547. Epub 2009 Mar 30. J Histochem Cytochem. 2009. PMID: 19332430 Free PMC article.

4

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations.

Szpurka H, Jankowska AM, Makishima H, Bodo J, Bejanyan N, Hsi ED, Sekeres MA, Maciejewski JP. Szpurka H, et al. Among authors: bodo j. Leuk Res. 2010 Aug;34(8):969-73. doi: 10.1016/j.leukres.2010.02.033. Epub 2010 Mar 23. Leuk Res. 2010. PMID: 20334914 Free PMC article.

5

Selection and validation of antibodies for signal transduction immunohistochemistry.

Bodo J, Hsi ED. Bodo J, et al. Methods Mol Biol. 2011;717:45-53. doi: 10.1007/978-1-61779-024-9_2. Methods Mol Biol. 2011. PMID: 21370023

6

HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells.

Bodo J, Sedlak J, Maciejewski JP, Almasan A, Hsi ED. Bodo J, et al. Apoptosis. 2011 Sep;16(9):914-23. doi: 10.1007/s10495-011-0617-x. Apoptosis. 2011. PMID: 21667043

7

Phosphoproteins and the dawn of functional phenotyping.

Bodo J, Hsi ED. Bodo J, et al. Pathobiology. 2011;78(2):115-21. doi: 10.1159/000296015. Epub 2011 Jun 14. Pathobiology. 2011. PMID: 21677474 Free article. Review.

8

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors.

Negrotto S, Ng KP, Jankowska AM, Bodo J, Gopalan B, Guinta K, Mulloy JC, Hsi E, Maciejewski J, Saunthararajah Y. Negrotto S, et al. Among authors: bodo j. Leukemia. 2012 Feb;26(2):244-54. doi: 10.1038/leu.2011.207. Epub 2011 Aug 12. Leukemia. 2012. PMID: 21836612 Free PMC article.

9

Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.

Warden DW, Ondrejka S, Lin J, Durkin L, Bodo J, Hsi ED. Warden DW, et al. Among authors: bodo j. Am J Surg Pathol. 2013 Feb;37(2):305-8. doi: 10.1097/PAS.0b013e3182712481. Am J Surg Pathol. 2013. PMID: 23211289

10

The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways.

Bodo J, Zhao X, Sharma A, Hill BT, Portell CA, Lannutti BJ, Almasan A, Hsi ED. Bodo J, et al. Br J Haematol. 2013 Oct;163(1):72-80. doi: 10.1111/bjh.12498. Epub 2013 Jul 25. Br J Haematol. 2013. PMID: 23889282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters